Chicago Equity Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Chicago Equity Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.41M	Sell	47,730 -12,755	-21%	-$432K	0.14%	212
2019 Q4	$2.19M	Sell	60,485 -40,890	-40%	-$1.25M	0.13%	242
2019 Q3	$2.76M	Sell	101,375 -3,430	-3%	-$88.7K	0.13%	232
2019 Q2	$2.52M	Buy	+104,805	New	+$2.66M	0.11%	263
2019 Q1	–	Sell	-169,445	Closed	-$3.31M	–	950
2018 Q4	$3.31M	Sell	169,445 -43,150	-20%	-$846K	0.13%	214
2018 Q3	$4.16M	Buy	212,595 +33,656	+19%	+$640K	0.12%	233
2018 Q2	$2.96M	Buy	+178,939	New	+$2.73M	0.09%	311
2017 Q4	–	Sell	-136,120	Closed	-$1.73M	–	876
2017 Q3	$1.73M	Buy	+136,120	New	+$1.73M	0.05%	402
2014 Q2	–	Sell	-25,250	Closed	-$381K	–	528
2014 Q1	$381K	Buy	25,250 +13,125	+108%	+$148K	0.01%	350
2013 Q4	$92K	Buy	+12,125	New	+$65.4K	﹤0.01%	410

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Chicago Equity Partners's HZNP Position: Q1 2020 in Review

Chicago Equity Partners reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 21% in Q1 2020, selling an estimated $432K and leaving 47,730 shares worth $1.41M. The position accounts for 0.14% of the portfolio, ranked #212.

Chicago Equity Partners first reported a position in HZNP in Q4 2013 and has held it in 10 quarters since. The position peaked at $4.16M in Q3 2018. 295 funds tracked by Wall St. Rank hold HZNP as of Q1 2020.

Chicago Equity Partners held 47,730 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1.41M as of Q1 2020.
Chicago Equity Partners sold 12,755 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2020, an estimated $432K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.14% of Chicago Equity Partners's portfolio in Q1 2020, its #212 holding.
Chicago Equity Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and has held it in 10 quarters since.
Chicago Equity Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.16M in Q3 2018.
295 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.